Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

0.00%

8.0¢ percheron therapeutics limited

UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE, page-5

First 5 Last

Share
Profile

Follow
arjay

3,549 Posts.

771

21/12/21

16:58

Post #: 58443218
Share

Originally posted by Uboy ↑

Terrible news indeed for the boy and his family.

This is not the first time Pfizer's GT program has been stopped due to "safety" concerns.

FDA has placed a clinical hold previously...and now they can add another couple of years on the sidelines.

This will have a negative impact on Sarepta's GT program too...and Roche by association.

As if the FDA wasn't already skeptical about the Gene Therapy approach for DMD...now this.

Where does that leave ANP?

mRNA tech is safe, we know that.

We also know ATL1102 achieved compelling efficacy results in Phase 2B.

ANP's Phase 3 program stands out as beacon of hope for the DMD community.

For Big Pharma - ANP can provide a short term hedge against the uknowns / mysteries yet to be solved with Gene Therapy.

We are talking 2 years with ATL1102 vs +10 years with GT.

IMO we will not see ANP sell drugs - ANP will be acquired by Pharma....just a matter of when?

Today's unfortunate news adds at least $100m to ANP's market cap...assuming FDA sidelines Pfizer for 2 years.

ANP is clearly the front runner now - and as Dr. G said "we want to own the DMD space".

What will Wilsons and Morgans say in their next update?
.

Expand

Top quality post...thanks mate

You missed something..and ANP is going to be over $20 / share...

ANP Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

RCE

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

AS1

Asara Resources sells off Burkina Faso assets to pivot into Guinea – for US$13M less than last time it tried

Bitcoin investors need to know the risks

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

There are more pages in this discussion • 73 more messages in this thread...

First 5 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.0¢		Change 0.000(0.00%)		Mkt cap ! $73.02M

Open	High	Low	Value	Volume
8.1¢	8.1¢	8.0¢	$28.87K	357.9K

Buyers (Bids)

No.	Vol.	Price($)
1	91851	7.9¢

Sellers (Offers)

Price($)	Vol.	No.
8.1¢	9362	2

View Market Depth

No.	Vol.	Price($)
1	91851	0.079
2	212658	0.078
1	200000	0.077
3	91500	0.076
4	206988	0.075

Price($)	Vol.	No.
0.081	9362	2
0.082	97561	1
0.083	214000	1
0.084	171142	3
0.085	141000	2

Last trade - 11.45am 15/07/2024 (20 minute delay)

PER (ASX) Chart